The SURMOUNT-1 trial specifically noted that participants with a BMI of 35 or higher who received the 15mg tirzepatide dose lost an average of 26.5% of their body weight, substantially higher than the overall trial average
The synthetic version of exendin-4, exenatide, shares a 53% amino acid sequence homology with human GLP-1 [18] and has been investigated in treating PD
Genetic abnormalities in large to giant congenital nevi: beyond NRAS mutations
Research in animal models has shown that central administration of DSIP can induce slow-wave sleep (SWS), also known as delta sleep, highlighting its potential importance in sleep quality and recovery
Acute gallbladder disease GLP-1 receptor agonists are associated with an increased risk of gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis)
This can have secondary implication on the host immune system due to potential increased translocation of bacteria and their metabolites [234]